|
UPDATE: 5/29/2023 - SB 403 died, it failed to get scheduled for a floor vote in the House before the end of session on 5/29/2023. HB 1313 died, it failed to pass the House Public Health Committee after having a hearing on 3/20/2023 before the end of session on 5/29/2023.
UPDATE: 5/18/2023 - SB 403 was considered in a formal meeting and passed without amendments on 5/18/2023 by vote of 7 Ayes, 4 Nays.
UPDATE: 4/28/2023 - SB 403 was referred to the House Public Health Committee on 4/28/2023.
UPDATE: 4/27/2023 - SB 403 passed 2nd and 3rd readings in the full Senate and was reported engrossed on 4/27/2023. View engrossed version HERE.
UPDATE 4/27/2023 - SB 403 is eligible for a vote in the full Senate and it is on the local and uncontested calendar. This means the bill is considered not controversial.
UPDATE: 4/17/2023 - SB 403 was passed as substituted by a committee substitute by the Senate Committee on Health & Human Services on 4/17/2023 by a vote of 9:0. The substitute mainly included clarifying language but it also changes the study to adverse events rather than "side effects." Also, the department will now collaborate instead with the University of Texas Science Center in Houston instead of the Health & Human Services Commission. The bill limits immediate short term, immediate serious, and long term serious effects studied to those mentioned in the bill by removing the words "but not limited to" after the word "including." These changes require a bill title change, but not a position change. Our previous title for SB 403 was "Requires Health & Human Services Commission in collaboration with the Dept. of Health to conduct a study on adverse reactions to COVID-19 vaccines " and this has been changed to "Requires Univ. of Texas Science Center in Houston in collaboration with the Dept. of Health to conduct a study on adverse events to COVID-19 vaccines"
UPDATE: 3/20/2023 - HB 1313 was heard in the House Public Health Committee on 3/20/2023 and was left pending in committee. Continue to contact the House Public Health Committee members until a vote is taken. Sometimes a vote is not taken on the day of the hearing.
UPDATE: 3/20/2023 - SB 403 is scheduled for a hearing in the Senate Committee on Health & Human Services on Wednesday, 3/22/2023, at 8:30 AM, in the Senate Chamber. The agenda can be viewed here.
UPDATE: 3/15/2023 - HB 1313 is scheduled for a hearing in House Public Health Committee on 3/20/2023 at 8:00 AM in JHR (John H. Reagan Building) Room 120. See agenda here.
You can provide written public testimony here – https://comments.house.texas.gov/home?c=c410
Register to present in-person testimony here – https://mytxlegis.capitol.texas.gov/HWRSPublic/About.aspx
Public access to the John H. Reagan Building is available only through the east entrance.
You can watch live video/audio here - https://house.texas.gov/video-audio/
HB 1313 was referred to the House Public Health Committee on 3/3/2023 and is sponsored by Representative Burrows.
SB 403 was referred to the Senate Health and Human Services Committee on 2/15/2023 and is sponsored by Senator Springer.
These bills require the Health and Human Services Commission, in collaboration with the Department of State Health Services, to conduct a study to assess the full and complete adverse reactions, including death, and effectiveness of each type of vaccine used in Texas for COVID-19.
The report must include immediate short-term side effects and adverse reactions, immediate serious side effects and adverse reactions recipients experienced, and any long-term side effects and adverse reactions recipients experienced from taking the various COVID-19 vaccines used in Texas.
The report also must include any misrepresentations about the effectiveness or dangers of taking of the vaccine by its manufacturers or any governmental agency and any concealment of information about the effectiveness or dangers of taking of the vaccine by its manufacturers or any governmental agency.
Information shall be gathered from the department’s vital statistics unit and the state Medicaid program, hospitals, treatment centers, available surveys, and other relevant sources.
Not later than January 1, 2024, the Commission and Department shall prepare and submit to the Governor, Lieutenant Governor, the Speaker of the House of Representatives, and the Chairpersons of the relevant Texas legislative committees with jurisdiction over the Commission and the Department, a copy of the report, summary of any findings, and any recommendations for legislative or executive action to reduce the prevalence of COVID-19 vaccine side effects. The department may post the report on the department ’s Internet website.
This bill is necessary because COVID-19 vaccines have a terrible safety profile and the federal Centers for Disease Control and Prevention (CDC) has not acknowledged the extent of this problem and has failed to protect the American people including Texans.
34,653 deaths have been reported to the Vaccine Adverse Event Reporting System (VAERS) from COVID-19 vaccines and 1,530,329 adverse events have been reported to VAERS where the Vaccine is either COVID-19 or COVID19-2 as of the 3/3/2023 release of VAERs data.
https://capitol.texas.gov/BillLookup/History.aspx?LegSess=88R&Bill=SB403 - text, status and history for SB 403
https://capitol.texas.gov/BillLookup/History.aspx?LegSess=88R&Bill=HB1313 - text, status and history for HB 1313
|